184 related articles for article (PubMed ID: 10730323)
1. [Application of magnetic resonance spectroscopy in the study of brain disease].
Pérez-Gómez M; Junqué C; Mercader JM; Berenguer J
Rev Neurol; 2000 Jan 16-31; 30(2):155-60. PubMed ID: 10730323
[TBL] [Abstract][Full Text] [Related]
2. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance spectroscopy in schizophrenia].
Delamillieure P; Constans JM; Fernandez J; Dollfus S
Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
[TBL] [Abstract][Full Text] [Related]
4. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration.
Block W; Träber F; Flacke S; Jessen F; Pohl C; Schild H
Amino Acids; 2002; 23(1-3):317-23. PubMed ID: 12373553
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.
De Stefano N; Bartolozzi ML; Guidi L; Stromillo ML; Federico A
J Neurol Sci; 2005 Jun; 233(1-2):203-8. PubMed ID: 15949506
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with 13C MRS in vivo.
Ross B; Lin A; Harris K; Bhattacharya P; Schweinsburg B
NMR Biomed; 2003; 16(6-7):358-69. PubMed ID: 14679500
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopy and its application to aging and Alzheimer's disease.
McClure RJ; Kanfer JN; Panchalingam K; Klunk WE; Pettegrew JW
Neuroimaging Clin N Am; 1995 Feb; 5(1):69-86. PubMed ID: 7743086
[TBL] [Abstract][Full Text] [Related]
10. A review of 1H MR spectroscopy findings in Alzheimer's disease.
Soher BJ; Doraiswamy PM; Charles HC
Neuroimaging Clin N Am; 2005 Nov; 15(4):847-52, xi. PubMed ID: 16443495
[TBL] [Abstract][Full Text] [Related]
11. Brain imaging in drug R&D.
Zijdenbos AP; Lerch JP; Bedell BJ; Evans AC
Biomarkers; 2005 Nov; 10 Suppl 1():S58-68. PubMed ID: 16298913
[TBL] [Abstract][Full Text] [Related]
12. [Proton magnetic resonance spectroscopy in the evaluation of cognitive disturbances].
Mathiesen HK; Nielsen AS; Nielsen K; Hanson LG
Ugeskr Laeger; 2006 Jan; 168(4):357-9. PubMed ID: 16436234
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.
De Stefano N; Filippi M; Miller D; Pouwels PJ; Rovira A; Gass A; Enzinger C; Matthews PM; Arnold DL
Neurology; 2007 Nov; 69(20):1942-52. PubMed ID: 17998486
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in Alzheimer's disease, a review.
Loos C; Achten E; Santens P
Acta Neurol Belg; 2010 Dec; 110(4):291-8. PubMed ID: 21305856
[TBL] [Abstract][Full Text] [Related]
16. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes.
Valenzuela MJ; Sachdev PS; Wen W; Shnier R; Brodaty H; Gillies D
Neuroimage; 2000 Dec; 12(6):747-56. PubMed ID: 11112406
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
Dedeoglu A; Choi JK; Cormier K; Kowall NW; Jenkins BG
Brain Res; 2004 Jun; 1012(1-2):60-5. PubMed ID: 15158161
[TBL] [Abstract][Full Text] [Related]
18. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
[TBL] [Abstract][Full Text] [Related]
19. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
[TBL] [Abstract][Full Text] [Related]
20. Perfusion magnetic resonance imaging in psychiatry.
Théberge J
Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
